Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from EFPIA

Where do Europeans wait longest for new medicines?

Access to new medicines still varies sharply across Europe, with waits ranging from months to more than three years, according to the European Federation of Pharmaceutical Industries and Associations.

Trump’s 15% tariff on medicines will harm patients, say EU drugmakers

Trump’s 15% tariff on medicines will harm patients, say EU drugmakers

Trade group says levy will reduce access, disrupt supply chains and cut R&D

The Guardian - UK

EU pharma chief calls for European Nasdaq to boost biotech innovation

EU pharma chief calls for European Nasdaq to boost biotech innovation

The head of the EU's pharmaceutical lobby has called for the creation of a life sciences-focused stock market in Europe, modelled after the US Nasdaq, to help retain biotech innovation and investment within the region.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Europe’s pharma titans confront von der Leyen as Trump plans ’major’ tariffs

Novo Nordisk and Sanofi were among the companies threatening to hasten their exits to the U.S., as Trump promised pharma tariffs were coming “shortly.”

Pharma companies warn EU Commission to negotiate and reduce non-tariff barriers

The EU executive and top pharmaceutical companies shared a video call to address concerns over potential US tariffs on drugs and other medical products.

Big Pharma versus the EU: who should pay for urban wastewater treatment?

The pharmaceutical and cosmetics industries have gone to the EU's court to challenge a directive that requires them to finance at least 80% of urban wastewater treatment.

Pharma company funding for patient advocacy groups needs to be transparent

Patient groups should be playing a central role in Canada’s health-care system, advocating for their members by promoting the visibility of their conditions, pushing for more rapid and accurate diagnoses and lobbying for the introduction and funding of new treatments and drugs that may help relieve their members’ symptoms and…

The Conversation

inkl

Read news from The Economist, FT, and more,
with one subscription

Novo Nordisk threatens to expand in US in row over EU rules

Novo Nordisk threatens to expand in US in row over EU rules

Novo Nordisk's CEO doesn't like proposed new EU rules that would cut the period for which drugmakers enjoy exclusivity for their products from 10 years to eight years.

1

People

189,901 stories

Ursula von der Leyen

Lars Fruergaard Jørgensen

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

The European Union

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

374,438 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play